For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Labcorp Holdings Inc (NYSE: LH) closed at $254.67 in the last session, up 0.37% from day before closing price of $253.73. In other words, the price has increased by $0.37 from its previous closing price. On the day, 0.68 million shares were traded. LH stock price reached its highest trading level at $257.505 during the session, while it also had its lowest trading level at $251.17.
Ratios:
We take a closer look at LH’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 35.30 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.29. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.55. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.67.
On April 02, 2025, Redburn Atlantic started tracking the stock assigning a Buy rating and target price of $276.
Citigroup Upgraded its Neutral to Buy on March 04, 2025, whereas the target price for the stock was revised from $250 to $300.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 11 ’25 when Schechter Adam H sold 5,745 shares for $262.75 per share. The transaction valued at 1,509,499 led to the insider holds 87,574 shares of the business.
Schechter Adam H bought 5,745 shares of LH for $1,509,499 on Nov 11 ’25. On Oct 31 ’25, another insider, Parham Richelle P, who serves as the Director of the company, sold 7,009 shares for $254.28 each. As a result, the insider received 1,782,273 and left with 2,469 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LH now has a Market Capitalization of 21163077632 and an Enterprise Value of 27113443328. As of this moment, Labcorp’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.01, and their Forward P/E ratio for the next fiscal year is 14.56. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.54. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.53 while its Price-to-Book (P/B) ratio in mrq is 2.43. Its current Enterprise Value per Revenue stands at 1.97 whereas that against EBITDA is 13.809.
Stock Price History:
The Beta on a monthly basis for LH is 1.02, which has changed by 0.09366381 over the last 52 weeks, in comparison to a change of 0.1877265 over the same period for the S&P500. Over the past 52 weeks, LH has reached a high of $293.72, while it has fallen to a 52-week low of $209.38. The 50-Day Moving Average of the stock is -1.61%, while the 200-Day Moving Average is calculated to be -1.44%.
Shares Statistics:
According to the various share statistics, LH traded on average about 788.46K shares per day over the past 3-months and 475700 shares per day over the past 10 days. A total of 83.00M shares are outstanding, with a floating share count of 82.65M. Insiders hold about 0.31% of the company’s shares, while institutions hold 97.17% stake in the company. Shares short for LH as of 1765756800 were 3152732 with a Short Ratio of 4.00, compared to 1763078400 on 3211771. Therefore, it implies a Short% of Shares Outstanding of 3152732 and a Short% of Float of 4.95.
Dividends & Splits
The forward annual dividend rate for LH is 2.88, which was 2.88 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.011350649. The current Payout Ratio is 32.58% for LH, which recently paid a dividend on 2025-11-26 with an ex-dividend date of 2025-11-26. Stock splits for the company last occurred on 2023-07-03 when the company split stock in a 1164:1000 ratio.
Earnings Estimates
The stock of Labcorp Holdings Inc (LH) is currently drawing attention from 15.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $4.11, with high estimates of $4.3 and low estimates of $3.98.
Analysts are recommending an EPS of between $16.41 and $16.16 for the fiscal current year, implying an average EPS of $16.33. EPS for the following year is $17.52, with 18.0 analysts recommending between $18.08 and $16.87.
Revenue Estimates
According to 13 analysts, . The current quarter’s revenue is expected to be $3.56B. It ranges from a high estimate of $3.61B to a low estimate of $3.5B. As of . The current estimate, Labcorp Holdings Inc’s year-ago sales were $3.33BFor the next quarter, 13 analysts are estimating revenue of $3.51B. There is a high estimate of $3.63B for the next quarter, whereas the lowest estimate is $3.46B.
A total of 17 analysts have provided revenue estimates for LH’s current fiscal year. The highest revenue estimate was $14.04B, while the lowest revenue estimate was $13.94B, resulting in an average revenue estimate of $13.99B. In the same quarter a year ago, actual revenue was $13.01BBased on 17 analysts’ estimates, the company’s revenue will be $14.62B in the next fiscal year. The high estimate is $14.99B and the low estimate is $14.47B.
